Consolidated Statements of Stockholders' Deficit - USD ($) shares in Thousands, $ in Thousands	Total	Convertible Note Principal	Convertible Note Principal The Mann Group L L C	Convertible Note Interest The Mann Group L L C	Common Stock	Common Stock Convertible Note Principal	Common Stock Convertible Note Principal The Mann Group L L C	Common Stock Convertible Note Interest The Mann Group L L C	Additional Paid-in Capital	Additional Paid-in Capital Convertible Note Principal	Additional Paid-in Capital Convertible Note Principal The Mann Group L L C	Additional Paid-in Capital Convertible Note Interest The Mann Group L L C	Accumulated Other Comprehensive Income	Accumulated Deficit
Beginning Balance at Dec. 31, 2022	$ (250,538)				$ 2,638				$ 2,964,293					$ (3,217,469)
Beginning Balance (in shares) at Dec. 31, 2022					263,793
Net issuance of common stock associated with restricted stock units and stock options	(10,162)				$ 41				(10,203)
Net issuance of common stock associated with restricted stock units and stock options (in shares)					4,169
Issuance of common stock pursuant to conversion notes				$ 222				$ 1				$ 221
Issuance of common stock pursuant to conversion notes (in shares)								51
Issuance of at-the-market offering	6,887				$ 15				6,872
Issuance of at-the-market offering (in shares)					1,478
Issuance costs associated with at-the-market offering	(108)								(108)
Issuance of common stock under the employee stock purchase plan	1,668				$ 5				1,663
Issuance of common stock under the employee stock purchase plan (in shares)					507
Issuance of common stock from market price stock purchase plan	152								152
Issuance of common stock from market price stock purchase plan (in shares)					36
Stock-based compensation expense	17,649								17,649
Net Income (Loss)	(11,938)													(11,938)
Ending Balance at Dec. 31, 2023	(246,168)				$ 2,700				2,980,539					(3,229,407)
Ending Balance (in shares) at Dec. 31, 2023					270,034
Net issuance of common stock associated with restricted stock units and stock options	(6,087)				$ 38				(6,125)
Net issuance of common stock associated with restricted stock units and stock options (in shares)					3,746
Issuance of common stock pursuant to conversion notes		$ 116,439	$ 3,750	$ 56		$ 267	$ 15	$ 0		$ 11,617	$ 3,735	$ 56
Issuance of common stock pursuant to conversion notes (in shares)						26,750	1,500	15
Issuance of common stock under the employee stock purchase plan	1,778				$ 5				1,773
Issuance of common stock under the employee stock purchase plan (in shares)					499
Issuance of common stock from market price stock purchase plan	1,361				$ 4				1,357
Issuance of common stock from market price stock purchase plan (in shares)					416
Stock-based compensation expense	21,358								21,358
Unrealized gain on available-for-sale securities	1,109												$ 1,109
Net Income (Loss)	27,588													(0)
Ending Balance at Dec. 31, 2024	(78,816)				$ 3,029				3,118,865				1,109	(3,201,819)
Ending Balance (in shares) at Dec. 31, 2024					302,960
Net issuance of common stock associated with restricted stock units and stock options	(3,262)				$ 43				(3,305)
Net issuance of common stock associated with restricted stock units and stock options (in shares)					4,272
Issuance of at-the-market offering	275
Issuance of common stock under the employee stock purchase plan	1,605				$ 5				1,600
Issuance of common stock under the employee stock purchase plan (in shares)					514
Issuance of common stock from market price stock purchase plan	387				$ 1				386
Issuance of common stock from market price stock purchase plan (in shares)					87
Stock-based compensation expense	24,195								24,195
Adjustment for impairment loss of available-for-sale investment included in net income	(1,269)												(1,269)
Unrealized gain on available-for-sale securities													275
Net Income (Loss)	5,863													5,863
Ending Balance at Dec. 31, 2025	$ (51,022)				$ 3,078				$ 3,141,741				$ 115	$ (3,195,956)
Ending Balance (in shares) at Dec. 31, 2025					307,833